Decade-long trends in atrial fibrillation incidence and survival: A community study

American Journal of Medicine

Volumn 128, Issue 3, 2015, Pages 260-267.e1

  Chamberlain, Alanna M ^a   Gersh, Bernard J ^a   Alonso, Alvaro ^b   Chen, Lin Y ^c   Berardi, Cecilia ^a   Manemann, Sheila M ^a   Killian, Jill M ^a   Weston, Susan A ^a   Roger, Véronique L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Atrial fibrillation; Epidemiology; Incidence Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART INFARCTION; HEMIPLEGIA; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARAPLEGIA; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; SMOKING; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; UNDERWEIGHT; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CONFIDENCE INTERVAL; EARLY DIAGNOSIS; INFORMATION PROCESSING; MINNESOTA; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; TRENDS;

AGE DISTRIBUTION; AGED; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CONFIDENCE INTERVALS; DATA COLLECTION; EARLY DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; MALE; MINNESOTA; MORTALITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 84924214657     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.10.030     Document Type: Article

References (38)

1. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
2. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
3. K.S. Coyne, C. Paramore, and S. Grandy Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States Value Health 9 2006 348 356
4. M.H. Kim, S.S. Johnston, and B.-C. Chu Estimation of total incremental health care costs in patients with atrial fibrillation in the United States Circ Cardiovasc Qual Outcomes 4 2011 313 320
5. W.C. Lee, G.A. Lamas, and S. Balu Direct treatment cost of atrial fibrillation in the elderly American population: A Medicare perspective J Med Econ 11 2008 281 298
6. E. Braunwald Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N Engl J Med 337 1997 1360 1369
7. G. Engstrom, M. Goransson, and O. Hansen Trends in long-term survival after myocardial infarction: less favourable patterns for patients from deprived areas J Intern Med 248 2000 425 434
8. K.C. Floyd, J. Yarzebski, and F.A. Spencer A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study Circ Cardiovasc Qual Outcomes 2 2009 88 95
9. V.L. Roger, S.A. Weston, and Y. Gerber Trends in incidence, severity, and outcome of hospitalized myocardial infarction Circulation 121 2010 863 869
10. W.D. Rosamond, L.E. Chambless, and G. Heiss Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008 Circulation 125 2012 1848 1857
11. H. Tunstall-Pedoe, K. Kuulasmaa, and M. Mahonen Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease Lancet 353 1999 1547 1557
12. R.W. Yeh, S. Sidney, and M. Chandra Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
13. G.C. Fonarow, J.T. Heywood, and P.A. Heidenreich Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 153 2007 1021 1028
14. S.W. Joffe, K. Webster, and D.D. McManus Improved survival after heart failure: A community-based perspective J Am Heart Assoc 2 2013 e000053
15. D. Levy, S. Kenchaiah, and M.G. Larson Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402
16. V.L. Roger, S.A. Weston, and M.M. Redfield Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
17. A. Alonso, S.K. Agarwal, and E.Z. Soliman Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 158 2009 111 117
18. J.P. Piccini, B.G. Hammill, and M.F. Sinner Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007 Circ Cardiovasc Qual Outcomes 5 2012 85 93
19. A.J. Camm, P. Kirchhof, and G.Y.H. Lip Guidelines for the management of atrial fibrillation Eur Heart J 31 2010 2369 2429
20. Y. Miyasaka, M.E. Barnes, and K.R. Bailey Mortality trends in patients diagnosed with first atrial fibrillation: A 21-year community-based study J Am Coll Cardiol 49 2007 986 992
21. L.J. Melton 3rd History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
22. J.L. St. Sauver, B.R. Grossardt, and B.P. Yawn Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project Am J Epidemiol 173 2011 1059 1068
23. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: A report from the American Heart Association Circulation 125 2012 e2 e220
24. B. Rockhill, B. Newman, and C. Weinberg Use and misuse of population attributable fractions Am J Public Health 88 1998 15 19
25. E.J. Benjamin, P.-S. Chen, and D.E. Bild Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop Circulation 119 2009 606 618
26. N.A.M. Estes 3rd, R.L. Sacco, and S.M. Al-Khatib American Heart Association atrial fibrillation research summit: A conference report from the American Heart Association Circulation 124 2011 363 372
27. J. Carlsson, S. Miketic, and J. Windeler Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
28. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial Lancet 356 2000 1789 1794
29. G. Opolski, A. Torbicki, and D.A. Kosior Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study Chest 126 2004 476 486
30. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
31. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
32. L. Testa, G.G.L. Biondi-Zoccai, and A. Dello Russo Rate-control vs. rhythm-control in patients with atrial fibrillation: A meta-analysis Eur Heart J 26 2005 2000 2006
33. D. Roy, M. Talajic, and S. Nattel Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
34. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
35. C.B. Granger, J.H. Alexander, and J.J.V. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
36. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
37. D. Capodanno, P. Capranzano, and G. Giacchi Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients Int J Cardiol 167 2013 1237 1241
38. J.L. St. Sauver, B.R. Grossardt, and C.L. Leibson Generalizability of epidemiological findings and public health decisions: An illustration from the Rochester Epidemiology Project Mayo Clin Proc 87 2012 151 160